Sonoma pharmaceuticals reports third quarter fy 2022 financial results

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its third fiscal quarter and nine months ended december 31, 2021. “we continue to reshape sonoma into a healthier company by divesting unprofitable product lines while
SNOA Ratings Summary
SNOA Quant Ranking